Genesis Automation's Power Play: New Leaders and AI for Healthcare Resilience

ST. PETERSBURG, Fla. – July 15, 2026 – Genesis Automation Healthcare, a company forged from the strategic merger of three distinct supply chain entities, is making a significant move to solidify its global leadership with the appointment of three senior executives. The announcement signals an aggressive push to scale its unified Clinical Lifecycle Management Platform, betting on deep industry experience and a forward-looking artificial intelligence strategy to solve some of healthcare's most persistent and costly problems.

The company has brought on Elizabeth Goddard as Senior Vice President of Global Sales, Patti Hoch as Global Vice President of Client Success, and Charles Ribeiro as Vice President of Product. The trio, who bring a combined 75 years of experience, joins the executive team just ahead of the AHRMM26 conference in San Antonio, a premier gathering for healthcare supply chain professionals, where they will be front and center. This calculated move underscores a pivotal moment for Genesis as it aims to deliver on its core promise: connecting patient safety directly to financial health.

"Elizabeth, Patti, and Charles bring exactly the leadership Genesis needs to continue scaling into new hospitals, NHS trusts, and health systems," said Jason Smith, President of Genesis, in the official announcement. "Three companies have become one, with one platform and one purpose: protecting patients and margins across the clinical lifecycle."

A New Guard for Global Ambitions

The new leadership team is a clear statement of intent. Each executive has been strategically chosen to helm a critical pillar of the company's growth. Elizabeth Goddard, now SVP of Global Sales, brings over two decades of go-to-market leadership from healthcare software giants like Infor and Lawson. Her remit is to expand the company's footprint across the United States, the United Kingdom, and Ireland, targeting health systems and NHS trusts that are increasingly looking for integrated solutions.

"Hospitals and health systems are asking for a different commercial conversation, one that connects patient safety to financial health rather than treating them as separate purchases," Goddard stated, highlighting the market's shift towards holistic value propositions. "That's what Genesis is built for, and it's why I joined this team."

Complementing this sales drive is Patti Hoch, a 25-year veteran of healthcare supply chain and logistics, who takes the reins of client success and professional services. With a background that includes leadership roles at Inova Health System and The Ohio State University Wexner Medical Center, as well as a distinguished military career, Hoch is tasked with translating the platform's capabilities into measurable results for its 400+ hospital sites.

"Every customer outcome we deliver has to, first and foremost, make patient care safer while driving operational and financial metrics," Hoch explained. "My team's job is to translate that visibility into measurable change in their hospitals."

Rounding out the trio is Charles Ribeiro, the new Vice President of Product, who will steer the company's product roadmap and, crucially, its AI strategy. With over 30 years in healthcare technology at firms like Omnicell and Teladoc, Ribeiro is charged with developing Genesis's first "agentic AI" capabilities, a technology that promises to move beyond simple analytics to autonomous action.

Unifying a Fragmented System

Genesis Automation Healthcare’s current market position is the result of a deliberate consolidation strategy. Backed by private equity firm Diversis Capital, the company was formed in late 2025 by combining Genesis (UK/Ireland), Kermit (US), and Meperia (US). The goal was to create an end-to-end platform to address the notorious "gap" in hospital operations—the costly and risk-prone space between where enterprise resource planning (ERP) systems stop at the warehouse door and electronic health records (EHRs) begin at the patient's bedside.

This gap often leads to financial leakage, compliance risks, and administrative bloat. Genesis tackles this by integrating with existing hospital systems rather than demanding a full replacement. Its unified platform is built on five pillars—Data, Sourcing, Inventory, Clinical, and Savings—with an overarching "Intelligence" layer. This structure allows it to clean and govern item master data, manage contracts, provide real-time inventory traceability from the loading dock to the point of use, and deliver spend management for high-cost physician preference items (PPIs). By providing a single source of truth, the platform aims to eliminate the data silos that plague health systems and prevent effective, system-wide decision-making.

The Promise of Agentic AI

The most forward-looking element of Genesis's strategy lies in its embrace of agentic AI, a concept Charles Ribeiro is tasked with bringing to life. Unlike traditional AI, which provides analysis and recommendations for human action, agentic AI systems are designed to perceive, reason, and act with a degree of autonomy. They can learn from real-world interactions and respond dynamically to complex, changing environments.

"Genesis is not simply bolting AI onto existing modules," Ribeiro asserted. "We are building an end-to-end unified AI platform across the clinical supply lifecycle."

The implications for a hospital supply chain are profound. An agentic AI could continuously monitor supply levels, predict shortages based on surgical schedules and public health data, automatically optimize stock across multiple facilities, and even initiate purchase orders—all while learning and improving. According to Ribeiro, the key differentiator is clinical context. "Because our agents understand the clinical context behind each procedure, they can accurately compare similar procedures and the items used within them to generate recommendations that are grounded in how care is delivered and significant to surgeons, supply chain teams, and CFOs," he said. This moves inventory management from a reactive, manual process to a proactive, self-optimizing system, promising significant cost savings and a reduction in the clinical risks associated with supply shortages.

Navigating a Transforming Market

Genesis's strategic hires and AI ambitions are well-timed. The healthcare supply chain sector is in the midst of a radical transformation, accelerated by the vulnerabilities exposed during the COVID-19 pandemic. Industry trends for 2026 point directly toward the solutions Genesis is championing: rapid digital transformation, a focus on supply chain resilience over "just-in-time" fragility, and the enterprise-scale adoption of AI. Nearly 70% of U.S. health organizations are expected to adopt cloud-based supply chain management by 2026, creating a fertile market for advanced platforms.

The market is also seeing significant consolidation, with private equity firms actively building end-to-end platforms through strategic acquisitions, mirroring the very process that created Genesis. By assembling a veteran leadership team and making a bold bet on next-generation AI, Genesis is positioning itself not just as a participant in this transformation, but as a potential leader, aiming to redefine the technological backbone of hospital operations for a more resilient and efficient future.